ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 18300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 18300; 2) Community: the network communities that were significantly associated with the response to NSC 18300; 3) Molecule: the relationships between components within communities and NSC 18300; 4) MDR: the compounds that were significantly associated with the NSC 18300.

NSC Compound Enrichment Correlation
NSC 681642 Camptothecin Derivative 0.0329129886465389 0.28684318
NSC 690043 Null 0.0329129886465389 0.23937033
NSC 693117 Null 0.0329129886465389 0.070577742
NSC 704565 Null 0.0329129886465389 0.033996835
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 0.0329129886465389 0.47631021
NSC 740510 6-(11-aminoundecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0329129886465389 0.01633985
NSC 742417 C8, carbonyl prodigiosine 0.0329129886465389 0.27835144
NSC 753193 N-(2-(4-acetylpiperazin-1-yl)ethyl)-3-(3-chloro-5-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.0329129886465389 0.18460364
NSC 758662 Lovastatin [USAN] 0.0329129886465389 0.069457453
NSC 193457 Null 0.0348993771550531 0.041360646
Total:82  Current:56    [First] [Prev] [Next] [Last]